{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:07:21Z","timestamp":1747202841655,"version":"3.40.5"},"reference-count":33,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,29]]},"DOI":"10.20945\/2359-3997000000340","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T18:25:53Z","timestamp":1617215153000},"source":"Crossref","is-referenced-by-count":7,"title":["Galanin and glypican-4 levels depending on metabolic and cardiovascular risk factors in patients with polycystic ovary syndrome"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-7443","authenticated-orcid":false,"given":"Sunduz Ozlem","family":"Altinkaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"1","key":"key20210331142541_B1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ogc.2014.09.003","article-title":"Endocrine and reproductive effects of polycystic ovarian syndrome","volume":"42","author":"Ecklund","year":"2015","unstructured":"1. Ecklund LC, Usadi RS. Endocrine and reproductive effects of polycystic ovarian syndrome. Obstet Gynecol Clin North Am. 2015;42(1):55-65.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"1","key":"key20210331142541_B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","unstructured":"2. Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.e25.","journal-title":"Fertil Steril"},{"issue":"2","key":"key20210331142541_B3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijgo.2009.09.021","article-title":"Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome","volume":"108","author":"Zhao","year":"2010","unstructured":"3. Zhao X, Zhong J, Mo Y, Chen X, Chen Y, Yang D. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2010;108(2):148-51.","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"key20210331142541_B4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2","volume":"21","author":"Goodman","year":"2015","unstructured":"4. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocr Pract. 2015;21(12):1415-26.","journal-title":"Endocr Pract"},{"issue":"1","key":"key20210331142541_B5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygcen.2012.07.029","article-title":"Galanin peptide family as a modulating target for contribution to metabolic syndrome","volume":"179","author":"Fang","year":"2012","unstructured":"5. Fang P, Yu M, Shi M, Zhang Z, Sui Y, Guo L, et al. Galanin peptide family as a modulating target for contribution to metabolic syndrome. Gen Comp Endocrinol. 2012;179(1):115-20.","journal-title":"Gen Comp Endocrinol"},{"issue":"1","key":"key20210331142541_B6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0014-5793(83)80033-7","article-title":"Galanin - A novel biologically active peptide from porcine intestine","volume":"164","author":"Tatemoto","year":"1983","unstructured":"6. Tatemoto K, R\u00f6kaeus A, J\u00f6rnvall H, McDonald TJ, Mutt V. Galanin - A novel biologically active peptide from porcine intestine. FEBS Lett. 1983;164(1):124-8.","journal-title":"FEBS Lett"},{"key":"key20210331142541_B7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-3-319-18440-1_36","article-title":"Selective expression of galanin in neuronal-like cells of the human carotid body","volume":"860","author":"Di Giulio","year":"2015","unstructured":"7. Di Giulio C, Marconi GD, Zara S, Di Tano A, Porzionato A, Pokorski M, et al. Selective expression of galanin in neuronal-like cells of the human carotid body. Adv Exp Med Biol. 2015;860:315-23.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"key20210331142541_B8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/pr.112.006536","article-title":"Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity","volume":"67","author":"Lang","year":"2015","unstructured":"8. Lang R, Gundlach AL, Holmes FE, Hobson SA, Wynick D, H\u00f6kfelt T, et al. Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity. Pharmacol Rev. 2015;67(1):118-75.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"key20210331142541_B9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.peptides.2012.05.016","article-title":"Galanin and its receptors: a novel strategy for appetite control and obesity therapy","volume":"36","author":"Fang","year":"2012","unstructured":"9. Fang P, Yu M, Guo L, Bo P, Zhang Z, Shi M. Galanin and its receptors: a novel strategy for appetite control and obesity therapy. Peptides. 2012;36(2):331-9.","journal-title":"Peptides"},{"key":"key20210331142541_B10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.peptides.2015.05.016","article-title":"Peptides: Basic determinants of reproductive functions","volume":"72","author":"Celik","year":"2015","unstructured":"10. Celik O, Aydin S, Celik N, Yilmaz M. Peptides: Basic determinants of reproductive functions. Peptides. 2015;72:34-43.","journal-title":"Peptides"},{"issue":"10","key":"key20210331142541_B11","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1210\/endo.139.10.6240","article-title":"Galanin is a paracrine inhibitor of gonadotroph function in the female rat","volume":"139","author":"Todd","year":"1998","unstructured":"11. Todd JF, Small CJ, Akinsanya KO, Stanley SA, Smith DM, Bloom SR. Galanin is a paracrine inhibitor of gonadotroph function in the female rat. Endocrinology. 1998;139(10):4222-9.","journal-title":"Endocrinology"},{"issue":"5","key":"key20210331142541_B12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000054696","article-title":"Stimulation of porcine pituitary luteinizing hormone release by galanin: putative auto\/paracrine regulation","volume":"74","author":"Elsaesser","year":"2001","unstructured":"12. Elsaesser F. Stimulation of porcine pituitary luteinizing hormone release by galanin: putative auto\/paracrine regulation. Neuroendocrinology. 2001;74(5):288-99.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"key20210331142541_B13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1083\/jcb.130.5.1207","article-title":"K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney","volume":"130","author":"Watanabe","year":"1995","unstructured":"13. Watanabe K, Yamada H, Yamaguchi Y. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J Cell Biol. 1995;130(5):1207-18.","journal-title":"J Cell Biol"},{"issue":"17","key":"key20210331142541_B14","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1073\/pnas.0601752103","article-title":"Evidence for a role of developmental genes in the origin of obesity and body fat distribution","volume":"103","author":"Gesta","year":"2006","unstructured":"14. Gesta S, Bl\u00fcher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S, et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A. 2006;103(17):6676-81.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"key20210331142541_B15","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/db11-1395","article-title":"Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine","volume":"61","author":"Ussar","year":"2012","unstructured":"15. Ussar S, Bezy O, Bl\u00fcher M, Kahn CR. Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes. 2012;61(9):2289-98.","journal-title":"Diabetes"},{"issue":"6","key":"key20210331142541_B16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00592-014-0652-5","article-title":"Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes","volume":"51","author":"Li","year":"2014","unstructured":"16. Li K, Xu X, Hu W, Li M, Yang M, Wang Y, et al. Glypican-4 is increased in human subjects with impaired glucose tolerance and decreased in patients with newly diagnosed type 2 diabetes. Acta Diabetol. 2014;51(6):981-90.","journal-title":"Acta Diabetol"},{"issue":"3","key":"key20210331142541_B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/09513590.2011.593670","article-title":"Pro12Ala PPAR \u03b32 gene polymorphism in PCOS women: the role of compounds regulating satiety","volume":"28","author":"Bidzi\u0144ska-Speichert","year":"2012","unstructured":"17. Bidzi\u0144ska-Speichert B, Lenarcik A, Tworowska-Bardzi\u0144ska U, Sl\u0119zak R, Bednarek-Tupikowska G, Milewicz A. Pro12Ala PPAR \u03b32 gene polymorphism in PCOS women: the role of compounds regulating satiety. Gynecol Endocrinol. 2012;28(3):195-8.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"key20210331142541_B18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09513590.2015.1110137","article-title":"Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study","volume":"32","author":"J\u0119drzejuk","year":"2016","unstructured":"18. J\u0119drzejuk D, Lwow F, Kuliczkowska-P\u0142aksej J, Hirnle L, Trzmiel-Bira A, Lenarcik-Kabza A, et al. Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study. Gynecol Endocrinol. 2016;32(3):223-6.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"key20210331142541_B19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"19. Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod.2004;19(1):41-7.","journal-title":"Hum Reprod"},{"key":"key20210331142541_B20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2840-12-106","article-title":"Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease","volume":"12","author":"Vonbank","year":"2013","unstructured":"20. Vonbank A, Saely CH, Rein P, Drexel H. Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease. Cardiovasc Diabetol. 2013;12:106.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"key20210331142541_B21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/1933719114522525","article-title":"Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome","volume":"21","author":"Clark","year":"2014","unstructured":"21. Clark NM, Podolski AJ, Brooks ED, Chizen DR, Pierson RA, Lehotay DC, et al. Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome. Reprod Sci. 2014;21(8):1034-43.","journal-title":"Reprod Sci"},{"issue":"9","key":"key20210331142541_B22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.clinbiochem.2012.12.013","article-title":"Circulating galanin levels are increased in patients with gestational diabetes mellitus","volume":"46","author":"Fang","year":"2013","unstructured":"22. Fang P, Bo P, Shi M, Yu M, Zhang Z. Circulating galanin levels are increased in patients with gestational diabetes mellitus. Clin Biochem. 2013;46(9):831-3.","journal-title":"Clin Biochem"},{"key":"key20210331142541_B23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.peptides.2014.01.024","article-title":"Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus","volume":"54","author":"Zhang","year":"2014","unstructured":"23. Zhang Z, Gu C, Fang P, Shi M, Wang Y, Peng Y, et al. Endogenous galanin as a novel biomarker to predict gestational diabetes mellitus. Peptides. 2014;54:186-9.","journal-title":"Peptides"},{"issue":"6","key":"key20210331142541_B24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jcjd.2017.01.001","article-title":"Serum Galanin Concentration is Increased in Subjects with Impaired Glucose Tolerance","volume":"41","author":"Zhang","year":"2017","unstructured":"24. Zhang Z, Fang P, Yu M, Wang Y, Li Y, Shi M, et al. Serum Galanin Concentration is Increased in Subjects with Impaired Glucose Tolerance. Can J Diabetes. 2017;41(6):563-6.","journal-title":"Can J Diabetes"},{"issue":"3","key":"key20210331142541_B25","first-page":"560","article-title":"Positive correlation of galanin with insulin resistance and triglyceride levels in obese children","volume":"48","author":"Acar","year":"2018","unstructured":"25. Acar S, Paket\u00e7i A, K\u00fcme T, Demir K, G\u00fcrsoy \u00c7alan \u00d6, B\u00f6ber E, et al. Positive correlation of galanin with insulin resistance and triglyceride levels in obese children. Turk J Med Sci. 2018;48(3):560-568.","journal-title":"Turk J Med Sci"},{"issue":"12","key":"key20210331142541_B26","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.peptides.2010.09.005","article-title":"Locus coeruleus galanin expression is enhanced after exercise in rats selectively bred for high capacity for aerobic activity","volume":"31","author":"Murray","year":"2010","unstructured":"26. Murray PS, Groves JL, Pettett BJ, Britton SL, Koch LG, Dishman RK, et al. Locus coeruleus galanin expression is enhanced after exercise in rats selectively bred for high capacity for aerobic activity. Peptides. 2010;31(12):2264-8.","journal-title":"Peptides"},{"key":"key20210331142541_B27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neubiorev.2015.09.012","article-title":"Crosstalk between exercise and galanin system alleviates insulin resistance","volume":"59","author":"Fang","year":"2015","unstructured":"27. Fang P, He B, Shi M, Zhu Y, Bo P, Zhang Z. Crosstalk between exercise and galanin system alleviates insulin resistance. Neurosci Biobehav Rev. 2015;59:141-6.","journal-title":"Neurosci Biobehav Rev"},{"key":"key20210331142541_B28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.exger.2015.11.007","article-title":"Type 2 diabetes mellitus as a disorder of galanin resistance","volume":"73","author":"Fang","year":"2016","unstructured":"28. Fang P, Shi M, Zhu Y, Bo P, Zhang Z. Type 2 diabetes mellitus as a disorder of galanin resistance. Exp Gerontol. 2016;73:72-7.","journal-title":"Exp Gerontol"},{"issue":"5","key":"key20210331142541_B29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/09513599909167578","article-title":"leptin, galanin and insulin in women with polycystic ovary syndrome","volume":"13","author":"Baranowska","year":"1999","unstructured":"29. Baranowska B, Radzikowska M, Wasilewska-Dziubi\u0144ska E, Kapli\u0144ski A, Roguski K, P\u0142onowski A. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Gynecol Endocrinol. 1999;13(5):344-51.","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"key20210331142541_B30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/humupd\/dms004","article-title":"Balancing ovulation and anovulation: integration of the reproductive and energy balance axes by neuropeptides","volume":"18","author":"Evans","year":"2012","unstructured":"30. Evans JJ, Anderson GM. Balancing ovulation and anovulation: integration of the reproductive and energy balance axes by neuropeptides. Hum Reprod Update. 2012;18(3):313-32.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"key20210331142541_B31","first-page":"383","article-title":"Serum glypican-4 levels are associated with metabolic syndrome in a Han population from Guizhou Province, China","volume":"32","author":"Ning","year":"2019","unstructured":"31. Ning DP, Xu K, Zhu HJ, Shan GL, Wang DM, Ping B, et al. Serum glypican-4 levels are associated with metabolic syndrome in a Han population from Guizhou Province, China. Biomed Environ Sci. 2019;32(5):383-8.","journal-title":"Biomed Environ Sci"},{"issue":"6","key":"key20210331142541_B32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/cen.13435","article-title":"Serum glypican 4 level in obese children and its relation to degree of obesity","volume":"87","author":"Leelalertlauw","year":"2017","unstructured":"32. Leelalertlauw C, Korwutthikulrangsri M, Mahachoklertwattana P, Chanprasertyothin S, Khlairit P, Pongratanakul S, et al. Serum glypican 4 level in obese children and its relation to degree of obesity. Clin Endocrinol (Oxf). 2017;87(6):689-95.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key20210331142541_B33","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1210\/jc.2012-4297","article-title":"Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease","volume":"98","author":"Yoo","year":"2013","unstructured":"33. Yoo HJ, Hwang SY, Cho GJ, Hong HC, Choi HY, Hwang TG, et al. Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2013;98(7):2897-901.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T18:26:20Z","timestamp":1617215180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972021005004203&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":33,"alternative-id":["10.20945\/2359-3997000000340"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000340","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"type":"print","value":"2359-3997"},{"type":"electronic","value":"2359-4292"}],"subject":[],"published":{"date-parts":[[2021,3,29]]}}}